Skip to content

Study to Evaluate The Ropan Effect of Dhataki Pushpa Churna On Shuddha Vrana

Randomized Open Controlled Clinical Study to Evaluate The Ropan Effect of Dhataki Pushpa Avachoornan On Shuddha Vrana - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078024
Enrollment
80
Registered
2024-12-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T07- Unspecified multiple injuries

Interventions

None listed

Sponsors

Dr Prajakta Parmeshwar Shinde
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient irrespective of gender, economic class, caste, religion. Patients having signs of suddha vrana having area less then length 5×5cmand max. depth upto 2cm, will be randomly selected. Traumatic wounds with no excessive loss of tissue or blood

Exclusion criteria

Exclusion criteria: Known cases of HIV, hepatitis B, any systemic disease. Medico-legal cases. Patients suffering from wounds like- having excessive loss of tissue, tubercular wounds, venous ulcer, leprotic ulcer, malignant Ulcer, burns,etc...

Design outcomes

Primary

MeasureTime frame
To study ropan effect of dhataki pushpa churna as external application once a day on shuddha vranaTimepoint: 15days

Secondary

MeasureTime frame
To study the mode of action of dhataki pushpa churna. To study mode of action of povidone-iodine . To assess the prognosis by subjective and objective parameters according to assessment criteria. To achieve outcome of study in 15 days.Timepoint: 15 days

Countries

India

Contacts

Public ContactVd Srinivas Turlapati

Yashwant Ayurveda Medical College PGT and RC Kodoli.

drsrinivast@gmail.com9503147698

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026